scholarly journals Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Stefano Kim ◽  
Bruno Buecher ◽  
Thierry André ◽  
Marine Jary ◽  
François-Clément Bidard ◽  
...  
Head & Neck ◽  
2014 ◽  
Vol 37 (11) ◽  
pp. 1665-1671 ◽  
Author(s):  
Min Yao ◽  
Nicholas Galanopoulos ◽  
Pierre Lavertu ◽  
Pingfu Fu ◽  
Michael Gibson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document